Abstract:Background: Achalasia is an oesophageal motility disorder, of unknown cause, which results in increased lower oesophageal sphincter (LOS) tone and symptoms of difficulty swallowing. Treatments are aimed at reducing the LOS tone. Current endoscopic therapeutic options include pneumatic dilation (PD) or botulinum toxin (BTX) injection. Objectives: To undertake a systematic review comparing the efficacy and safety of two endoscopic treatments, PD and intrasphincteric BTX injection, in the treatment of oesophageal achalasia. Search methods: Trials were initially identified by searching MEDLINE (1966 to August 2008), EMBASE (1980 to September 2008), ISI Web of Science (1955 to September 2008), The Cochrane Library Issue 3, 2008. Searches in all databases were conducted in October 2005 and updated in September 2008 and April 2014. The Cochrane highly sensitive search strategy for identifying randomised trials in MEDLINE, sensitivity maximising version in the Ovid format, was combined with specific search terms to identify randomised controlled trials in MEDLINE. The MEDLINE search strategy was adapted for use in the other databases that were searched. Selection criteria: Randomised controlled trials comparing PD to BTX injection in individuals with primary achalasia. Data collection and analysis: Two review authors independently performed study quality assessment and data extraction. Main results: Seven studies involving 178 participants were included. Two studies were excluded from the meta-analysis of remission rates on the basis of clinical heterogeneity of the initial endoscopic protocols. There was no significant difference between PD or BTX treatment in remission within four weeks of the initial intervention; with a risk ratio of remission of 1.11 (95% CI 0.97 to 1.27). There was also no significant difference in the mean oesophageal pressures between the treatment groups; with a weighted mean difference for PD of -0.77 (95% CI -2.44 to 0.91, P = 0.37). Data on remission rates following the initial endoscopic treatment were available for three studies at six months and four studies at 12 months. At six months 46 of 57 PD participants were in remission compared to 29 of 56 in the BTX group, giving a risk ratio of 1.57 (95% CI 1.19 to 2.08, P = 0.0015); whilst at 12 months 55 of 75 PD participants were in remission compared to 27 of 72 BTX participants, with a risk ratio of 1.88 (95% CI 1.35 to 2.61, P = 0.0002). No serious adverse outcomes occurred in participants receiving BTX, whilst PD was complicated by perforation in three cases. Authors' conclusions: The results of this meta-analysis suggest that PD is the more effective endoscopic treatment in the long term (greater than six months) for patients with achalasia.

Comparison of Endoscopic Balloon Dilation with Metal Stent Placement in the Treatment of Achalasia

Comparison of Endoscopic Balloon Dilation with Surgical Therapy in Management of Esophageal Achalasia

Method Selection and Evaluation of Midtrimester and Long-Term Therapeutic Efficiency of Achalasia with Three Methods of Interventional Procedure

Improvement of Endoscopical Therapy for Achalasia

Interventional therapy of achalasia with temporary metal internal stent dilatation and its intermediate and long term follow-up

Treatment of Achalasia with Endoscopic Balloon Dilatation.

Bypassing Large Submucosal Vessels During Peroral Endoscopic Myotomy Reduces Operative Time and Intraoperative Blood Loss in Patients with Achalasia

Long-term follow-up study of dilation with temporary cardia stent in different diameters for achalasia

A Systematic Review and Meta-Analysis of the Chinese Literature for the Treatment of Achalasia

Autonomic and Neuroendocrine Responses to Rectosigmoid Stimulation

[Efficacy and Safety of Digestive Tract Stent Placement under Direct Visual Endoscopy Without X-ray Monitoring in Treatment of Digestive Tract Stricture].

Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia

Endoscopic Balloon Retained and Intermittent Dilation in the Treatment of Benign Esophageal Stenosis: an Analysis of 30 Cases

Effectiveness of Peroral Endoscopic Myotomy in the Treatment of Achalasia: A Pilot Trial in Chinese Han Population with a Minimum of One‐year Follow‐up

Metal stent dilation in the treatment of benign esophageal stricture by interventional procedure: a follow-up study

Comparative Quality of Life Study Between Endoscopic Sphincterotomy and Surgical Choledochotomy

Comparison of esophageal stent placement versus endoscopic incision method for treatment of refractory esophageal anastomotic stricture

Percutaneous treatment of bilioenteric anastomotic strictures: Comparison of long-term outcomes between temporary covered stents and balloon dilation

Peroral Endoscopic Myotomy for Treating Achalasia Performed by a Gastroenterologist: 4 Yearsʼ Experience from a Single Endoscopy Center

The Clinical Efficacy, and Long-Term Outcomes Between Pneumatic Dilation and Laparoscopic Heller Myotomy in Achalasia

Membrane-covered Self-Expanding Stents in the Treatment of High-Positioned Esophageal Stenosis or Fistula